QDEL (STOCKS)
QuidelOrtho Corporation Common Stock
$14.360000
+0.230000 (+1.63%)
Prev close: $14.130000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Brian J. Blaser
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $995.59M
- Employees
- 6,600
- P/E (TTM)
- -0.82
- P/B (TTM)
- 0.52
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $2.33B |
| Benefits Costs and Expenses | $1.03B |
| Cost Of Revenue | $616.58M |
| Costs And Expenses | $406.36M |
| Gross Profit | $1.71B |
| Operating Expenses | $406.36M |
| Research and Development | $98.77M |
| Other Operating Expenses | $283.30M |
| Operating Income/Loss | $1.30B |
| Income/Loss From Continuing Operations After Tax | $1.01B |
| Income/Loss From Continuing Operations Before Tax | $1.30B |
| Income Tax Expense/Benefit | $293.10M |
| Income Tax Expense/Benefit, Deferred | $24.14M |
| Net Income/Loss | $1.01B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $1.01B |
| Net Income/Loss Available To Common Stockholders, Basic | $1.01B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Diluted Earnings Per Share | $23.55 |
| Basic Average Shares | 125,715,000 |
| Diluted Average Shares | 127,689,000 |
| Assets | $3.09B |
| Current Assets | $2.11B |
| Inventory | $181.39M |
| Prepaid Expenses | $17.44M |
| Other Current Assets | $1.91B |
| Noncurrent Assets | $979.48M |
| Fixed Assets | $364.25M |
| Intangible Assets | $91.58M |
| Other Non-current Assets | $523.64M |
| Liabilities | $678.20M |
| Current Liabilities | $492.66M |
| Accounts Payable | $157.47M |
| Wages | $27.82M |
| Other Current Liabilities | $307.36M |
| Noncurrent Liabilities | $185.55M |
| Equity | $2.41B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.41B |
| Liabilities And Equity | $3.09B |
| Net Cash Flow From Operating Activities | $721.38M |
| Net Cash Flow From Operating Activities, Continuing | $721.38M |
| Net Cash Flow From Investing Activities | -$279.63M |
| Net Cash Flow From Investing Activities, Continuing | -$279.63M |
| Net Cash Flow From Financing Activities | -$146.94M |
| Net Cash Flow From Financing Activities, Continuing | -$146.94M |
| Exchange Gains/Losses | -$332.00K |
| Net Cash Flow | $294.48M |
| Net Cash Flow, Continuing | $294.82M |
| Comprehensive Income/Loss | $1.01B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $1.01B |
| Other Comprehensive Income/Loss | $771.33M |